本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Compugen醫療

1.44
-0.0400-2.70%
成交量:7.53萬
成交額:10.86萬
市值:1.35億
市盈率:-9.00
高:1.47
開:1.44
低:1.42
收:1.48
資料載入中...
2025/03/04

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/03/05

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/08/23

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2023/08/23

SEC問詢函

Form CORRESP - Correspondence
2023/06/23

SEC問詢函

Form CORRESP - Correspondence
2023/04/14

SEC問詢函

Form CORRESP - Correspondence
2023/02/28

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/08/04

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/28

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/28

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/07/28

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/05/13

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/25

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/25

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals